Wang, X., Herzog, R. W., Byrne, B. J., Kumar, S. R., Zhou, Q., Buchholz, C. J., & Biswas, M. (2017). Immune Modulatory Cell Therapy for Hemophilia B Based on CD20-Targeted Lentiviral Gene Transfer to Primary B Cells. Mol Ther Methods Clin Dev.
Chicago Stili AlıntıWang, Xiaomei, Roland W. Herzog, Barry J. Byrne, Sandeep R.P Kumar, Qi Zhou, Christian J. Buchholz, ve Moanaro Biswas. "Immune Modulatory Cell Therapy for Hemophilia B Based On CD20-Targeted Lentiviral Gene Transfer to Primary B Cells." Mol Ther Methods Clin Dev 2017.
MLA AlıntıWang, Xiaomei, et al. "Immune Modulatory Cell Therapy for Hemophilia B Based On CD20-Targeted Lentiviral Gene Transfer to Primary B Cells." Mol Ther Methods Clin Dev 2017.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..